Your browser doesn't support javascript.
loading
Patterns of cardio-respiratory motor outputs during acute and subacute exposure to chlorpyrifos in an ex-vivo in situ preparation in rats.
Felippe, Igor S A; Müller, Claudia J T; Passamani, Luciana M; Abdala, Ana P; Paton, Julian F R; Sampaio, Karla N.
Affiliation
  • Felippe ISA; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil; The Centre for Heart Research - Manaaki Manawa, Department of Physiology, Faculty of Health & Medical Sciences, University of Auckland, Grafton Campu
  • Müller CJT; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil.
  • Passamani LM; Brazilian Hospital Services Company, Federal University of Espírito Santo, Vitória, ES, Brazil.
  • Abdala AP; Department of Physiology, Pharmacology & Neuroscience, Biomedical Sciences, University of Bristol, Bristol BS8 ITD, United Kingdom.
  • Paton JFR; The Centre for Heart Research - Manaaki Manawa, Department of Physiology, Faculty of Health & Medical Sciences, University of Auckland, Grafton Campus, Auckland 1023, New Zealand.
  • Sampaio KN; Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil. Electronic address: karla.sampaio@ufes.br.
Toxicol Appl Pharmacol ; 436: 115862, 2022 02 01.
Article de En | MEDLINE | ID: mdl-34998853
ABSTRACT
While a considerable body of literature has characterized the clinical features induced by organophosphate pesticides, the field lacks scrutiny into cardio-respiratory changes in different phases of poisoning. Herein, we evaluated the impact of chlorpyrifos (CPF) and its active metabolite chlorpyrifos-oxon (CPO) on the cardiorespiratory system during acute and subacute phases of poisoning using an in situ experimental rodent model. CPF (30 mg/kg) was injected intraperitoneally to rats beforehand (24 h) whereas CPO (15 mg/kg) was added into the perfusate reservoir to evaluate the effects on the motor outputs throughout the three phases of the respiratory cycle inspiration, post-inspiration and late expiration. Phrenic, recurrent laryngeal (RLN) and thoracic sympathetic nerve activity (tSNA) were recorded. Heart rate was derived from the electrocardiogram (ECG) and the baro- and chemo-reflexes tested. CPF and CPO led to a time-dependent change in cardiorespiratory motor outputs. In the acute phase, the CPO induced bradypnea, transiently reduced the inspiratory time (TI), and increased the amplitude of phrenic. Post-inspiratory (PI) discharge recorded from the RLN was progressively reduced while tSNA was increased. CPO significantly depressed the chemoreflex but had no effect on baroreflex. During subacute phase, CPF prolongated TI with no effect on respiratory rate. Both the RLN PI discharge, the chemoreflex and the baroreflex sympathetic gain were reduced. In addition, both CPF and CPO shifted the cardiac sympatho-vagal balance towards sympathetic dominance. Our data show that different phases of poisoning are associated with specific changes in the cardio-respiratory system and might therefore demand distinct approaches by health care providers.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Appareil respiratoire / Baroréflexe / Chlorpyriphos / Coeur / Rythme cardiaque Limites: Animals Langue: En Journal: Toxicol Appl Pharmacol Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Appareil respiratoire / Baroréflexe / Chlorpyriphos / Coeur / Rythme cardiaque Limites: Animals Langue: En Journal: Toxicol Appl Pharmacol Année: 2022 Type de document: Article